Gilead Sciences GmbH
Track this competitor Create a free account to be notified when it wins a contract.
- Contracts won
- 4
- Amount won alone
- €216,000 excl. VAT
- Shared contracts
- 2 (multi-supplier framework agreements)
- Period
- 15 July 2026 – 22 October 2026
Its main clients
- Dirección General de Gestión Económica, Contratación e Infraestructuras de la Conselleria de Sanidad · 1 contract
- Regione Autonoma della Sardegna · 1 contract
- AOK PLUS - Die Gesundheitskasse für Sachsen und Thüringen · 1 contract
- AOK Baden-Württemberg · 1 contract
Where and what
Supplies · 4
Its contracts coming to an end
So many opportunities to take over these contracts when they are re-tendered.
| Planned end | Contract | Current holder | Amount |
|---|---|---|---|
| 30 June 2028 re-tender around December 2027 |
Arzneimittelrabattvereinbarung gemäß § 130c Abs. 1 SGB V zu der Wirkstofffixkombination Sofosbuvir/Velpatasvir
AOK Baden-Württemberg framework agreement |
Gilead Sciences GmbH 1 bid received |
€216,000 |
| 31 August 2028 re-tender around March 2028 |
Vereinbarung nach § 130c Abs. 1 SGB V für das Arzneimittel Epclusa mit der Wirkstoffkombination Sofosbuvir/Velpatasvir
AOK PLUS - Die Gesundheitskasse für Sachsen und Thüringen framework agreement |
Gilead Sciences GmbH 1 bid received |
€0 |
Contracts won
Source: contract award notices published on TED (Publications Office of the European Union), above the EU thresholds. Contracts published only in Belgium are not included yet.